TTS Educational Committee started Hot Off the Press in April 2020, after the COVID-19 pandemic, to review important 3-5 articles related to COVID-19 and transplantation. The aim was to inform TTS members about new and important publications. The initiative has received good feedback. We plan to continue New Hot Off The Press weekly to and feature important manuscripts from high impact journals on the following topics: (view right panel).
Establishment of Solid Organ Transplantation in the United Arab Emirates #TBT bit.ly/3NisUH7One of the key unmet areas of medical need in the [United Arab Emirates] was the availability of solid organ transplantation. Collaborative efforts began a few years ago aiming to establish thoracic and abdominal solid organ transplantation from deceased donors in addition to continued development of the existing program in kidney transplantation from living donors. This report summarizes the culmination of those efforts, representing close collaboration between various entities and stakeholders working toward the common goal of enabling citizens and residents of the UAE access to transplant services of the highest quality.
Magnetic Resonance Elastography-derived Stiffness Predicts Renal Function Loss and Is Associated With Microvascular Inflammation in Kidney Transplant Recipients #magneticresonance #OpenAccess #TransplantTwitter bit.ly/3u5923tOrgan stiffening can be caused by inflammation and fibrosis, processes that are common causes of transplant kidney dysfunction. Magnetic resonance elastography (MRE) is a contrast-free, noninvasive imaging modality that measures kidney stiffness. The objective of this study was to assess the ability of MRE to serve as a prognostic factor for renal outcomes.
The slogan we adopted for the TTS 2022 Congress is "Committed to Access and Transparency" and as a lead-up to the Congress we have launched a new needs assessment survey which will aid TTS in developing new programs, educational material and strategies to better improve access and transparency in the field of transplantation. As a non-governmental organization in official relations with the World Health Organization (WHO) the information collected will feed into the work TTS is doing as part of our WHO collaboration.
Your support, by completing this survey, will contribute to the success of this initiative. Your answers will be kept confidential and anonymous.
The symposium will connect clinicians, researchers and patients from around the globe. The aim is to explore the needs and define the areas for future research. It is organized in close collaboration with the Women in Transplantation (WIT) initiative of The Transplantation Society (TTS) and exclusively funded by the German VolkwagenStiftung. Please find details on the program by visiting our website: https://diversity-in-transplantation.org/
We welcome you to support us by joining our hybrid symposium. You are welcome to submit an abstract of either original research or summarize clinical, research, societal or patient related aspects related to the symposium’s topic. We are able to provide travel grants to a limited number of participants. Please see the website for more details.
If there are any questions, please do not hesitate to contact us. Click the links below for the preliminary program and the template for abstract submission.
Cytomegalovirus (CMV) is one of the most common viral infections in the post-transplant setting, including solid organ transplant (SOT) and hematopoietic cell transplant (HCT). CMV conveys a high risk of complications including graft loss, morbidity, and mortality. There are currently no FDA approved therapies for CMV after transplantation and those that are currently in use have serious side effects including kidney and bone marrow toxicity. Data from RMEI medical education programs, as well as information gleaned from CMV experts including TTS Education Committee Member, Camille Kotton MD, show that clinicians who treat CMV in transplant patients need guidance regarding which CMV therapies to choose and how to incorporate a new antiviral (maribavir) in clinical practice.
The Resistant/Refractory Cytomegalovirus Clinical Decision Support Tool (CDST) has been built using the algorithm of the Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation by Camille Kotton, MD et al.
This edition of the Journal Watch focuses mainly on aspects of system development, from how to measure and compare performance metrics to what are the signs of work-related issues we should be monitoring in donor coordinators. There is an analysis of how even similarly structured systems in the UK and Australia can be very difficult to compare using currently collected data. There is also a report from an international round table exploring how donation after voluntary euthanasia (also known as medical assistance in dying) has been integrated into end-of-life care in a few countries and a description of DCD protocol variations in the area covered by an organ donation organization in the United States, and others.
Sonny Dhanani (Associate Director, CDTRP and Chair of the Canadian Donation Physician Network)
Matthew Weiss (Medical Director - Organ Donation at Transplant Québec and National Lead of the LEADDR Research Program, CDTRP)
The Transplantation Society
740 Notre-Dame Ouest
Montréal, QC, H3C 3X6